Summary The products of ras and src proto-oncogenes are frequently activated in a constitutive state in human colorectal cancer. In this study we attempted to establish whether the tumorigenic progression induced by oncogenic activation of p21'as and pp6Ocsrc in human colonic Caco-2 cells is associated with specific alterations of syndecan-1, a membrane-anchored proteoglycan playing a role in cell-matrix interaction and neoplastic growth control. To this end, we used Caco-2 cells made highly tumorigenic by transfection with an activated (Val 12) human Ha-ras gene or with the polyoma middle T (Py-MT) oncogene, a constitutive activator of pp6Oc-src tyrosine kinase activity. Compared with control vector-transfected Caco-2 cells, both oncogene-transfected cell lines (1) contained smaller amounts of membrane-anchored PGs; (2) exhibited decreased syndecan-1 expression at the protein but not the mRNA level; (3) synthesised 35S-labelled syndecan-1 with decreased specific activity; (4) produced a syndecan-1 ectodomain with a lower molecular mass and reduced GAG chain size and sulphation; and (5) expressed heparanase degradative activity. These results show that the dramatic activation of the tumorigenic potential induced by oncogenic p2l" or Py-MT/pp60csrc in Caco-2 cells is associated with marked alterations of syndecan-1 expression at the translational and posttranslational levels.
Human colorectal cancer, the second most common cause of death in developed countries, is now thought to result from a series of genetic alterations. The most frequent alterations consist of point mutations in members of the ras gene family (Bos et al., 1987) which encode closely related Mr 21 000 guanine nucleotide-binding proteins (p2lIr-S) or in activation of the pp6O phosphoprotein encoded by the proto-oncogene c-src (Bolen et al., 1987; Cartwright et al., 1990) . The high frequency of these alterations strongly suggests that p2Iras and pp6oc-src oncoproteins, both of which are involved in growth factor signal transduction pathways, play a central role in human colon carcinogenesis.
Cell transformation is frequently associated with specific defects in the basement membrane, which play a critical role in tumour growth, invasion and metastasis (Liotta et al., 1986; Yamada, 1983) . These defects result mainly from the presence of specific enzymes involved in degradation of extracellular matrix constituents (Matrisian, 1992) , and also from significant modifications in cell surface proteoglycans (PGs) (lozzo, 1985) . Specific qualitative and quantitative changes in PGs have been reported in various transformed cells. We previously demonstrated that the expression of PGs alters considerably in intestinal epithelial cells after oncogene immortalisation, representative of an early stage of neoplastic transformation (Levy et al., 1990) . Elevated concentrations of hyaluronic acid have been demonstrated in breast carcinomas and human gliomas (Glimelius et al., 1978) , and increased amounts of chondroitin sulphate (CS) PGs have been shown in cancer cells from liver (Kojima et al., 1975) and in colon cancer (lozzo and Wight, 1982) . Transformed cells are known to exhibit a reduced amount of undersulphated heparan sulphate (HS) (Winterbourne and Mora, 1978) and some authors have suggested that there is a relationship between decreased HS content and increased activity of heparanase, an enzyme which specifically degrades HS chains (Ricoveri and Capelleti, 1986; Nakajima et al., 1984) . Such alterations in the amount and degree of sulphation of HS may help to reduce cell matrix adhesion and thus favour tumour cell shedding from primary tumours (lozzo, 1988) .
Among the HS PGs, the syndecans, which constitute most of the transmembrane PGs, appear to have a profound influence on fundamental features of cell behaviour such as adhesion, matrix anchorage and growth control (David, 1993) . The syndecan family consists of at least four members that differ considerably in their extracellular domains but exhibit high degrees of homology in their transmembrane and cytoplasmic domains ). Syndecan-1, which is found mainly on the surfaces of epithelial cells in mature tissues, is the one that has been most thoroughly characterised so far (Saunders et al., 1989) . It plays a key role in the maintenance of the epithelial cell phenotype by anchoring cytoskeletal actin to the extracellular matrix (ECM) (Rapraeger et al., 1986 ) and behaves like a matrix receptor, by binding to a variety of ECM components (Saunders and Bernfield, 1988; Sanderson et al., 1992a) . Despite the importance of the interaction between transformed cells and the surrounding matrix as a regulatory factor controlling the growth of these cells, there are only a few studies dealing with the effects of malignant transformation on syndecan-1. Loss of syndecan-1 expression occurs in experimental tumours induced by UV-irradiation of murine skin (Inki et al., 1991) , by glucocorticoid exposure of mouse mammary epithelial cells (Leppa et al., 1991; Kirjavainen et al., 1993) and in the malignant transformation of human keratinocytes (Inki et al., 1994) .
However, there is to our knowledge, no information about the changes of syndecan-1 associated with ras and src oncogene-mediated neoplastic colorectal transformation. To address this issue, we used human colon carcinoma cells Caco-2 which had been transfected with a plasmid vector recombined either with an activated (Val 12) human c-Ha-ras gene (Caco-2-T cells), or with the cDNA encoding the Py-MT antigen, a constitutive activator of the tyrosine kinase of pp6Oc-src (Caco-2 MT cells). Since parental Caco-2 cells are known to display a very low tumorigenicity (Rousset et al., 1980; Trainer et al., 1988) , these ras-and Py-MT-transfected Caco-2 cells, recently shown to be highly tumorigenic in nude mice (Chastre et al., 1993; Delage et al., 1993) Cell lines Human colon carcinoma cells Caco-2 were transfected by electroporation, as previously described (Chastre et al., 1993) . Homer 6, a plasmid vector containing a MoMSVLTR-driven G418 resistance gene, which was recombined either with the cDNA encoding the Py-MT antigen (pHO6MT1) or with a mutated (Val 12) human Ha-ras gene (pHO6T1) was used for cell transfection. Caco-2 cells transfected with the plasmids Homer 6, pHO6MT1 or pHO6T1, were designated as Caco-2-H, Caco-2-MT and Caco-2-T cells respectively (Chastre et al., 1993; Delage et al., 1993) . The oncogene-transfected Caco-2-MT and Caco-2-T cells are regularly verified for overexpression of PKC-o mRNA transcripts (Delage et al., 1993) , which is taken as an index of maintenance of functional oncogenes in these cell lines.
Cells were routinely grown at 37°C on 100 mm diameter dishes in a humidified incubator equilibrated with 5% carbon dioxide using Dulbecco's modified Eagle medium (DMEM) (4.5 gl-l glucose) supplemented with 15% fetal calf serum,Isolation of transmembrane PGs Control Caco-2-H and oncogene-transfected Caco-2-MT and Caco-2-T cells were incubated with Na235SO4 (50 mCi ml-') for 24 h. After labelling, cell monolayers were washed twice in ice-cold calcium-and magnesium-free phosphate-buffered saline (PBS). An extraction protocol using a detergent cell lysis buffer was designed to obtain cellular fractions enriched in plasma membrane-associated PGs (Yanagishita and Hascall, 1984 (Yeaman and Rapraeger, 1993) . Before hydrophobic chromatography, aliquots of the purified PGs were diluted 20-fold to reduce the detergent concentration.
Hydrophobic affinity chromatography The hydrophobic properties of the detergent-extracted 35S-PGs purified by ion-exchange chromatography were determined by gel chromatography on Octyl-Sepharose CL-4B. Columns (2 ml) were equilibrated with 4 M guanidinium hydrochloride (Gdn HCl)-50 mM sodium acetate (pH 7.0). After washing with the same buffer, columns were eluted with a 50 ml gradient of Triton X-100 (0-0.8%) in the Gdn HCl buffer. Fractions (1 ml) were analysed for the Triton X-100 concentration by absorbance at 280 nm and for 35S radioactivity by liquid scintillation counting.
Biochemical characterisation of syndecan-l Expression of syndecan-1 in control and oncogene-transfected Caco-2 cells was analysed by Northern blot and immunoblot analyses. For Northern blot analysis, RNA samples containing 30 ,ig of total RNA were electrophoresed through 1% agarose-6% formaldehyde gels, blotted onto Hybond-N nylon membranes (Amersham) and hybridised with a mega-prime-labelled cDNA probe specific for syndecan-1 (Saunders et al., 1989) . After hybridisation, blots were washed at 65°C to high stringency, (0.1 x SSC, 0.1% SDS), and exposed to Kodak X-Omat AR film with intensifying screens at -80°C. RNA was quantified and normalised by differential densitometric scanning of syndecan-I bands vs the 28S rRNA bands .
For immunoblot analysis, PG-enriched fractions were prepared from detergent extracts of cells and partially purified as indicated previously (Inki et al., 1994) . Samples were fractionated by SDS-PAGE (2-20% gradient) in Tris borate buffer (Jalkanen et al., 1985) , and electrophoretically transferred to Immobilon-N membranes. Membranes were then probed with MAb 281-2, an antibody which recognises the core protein of syndecan-1 (generous gift from Dr M Bernfield, Harvard Medical School, Boston, MA, USA). Detection of immunoreactive protein was performed with the RPN Amersham enhanced chemiluminescence Western blotting detection system.
Isolation of the syndecan-I ectodomain
The syndecan-1 ectodomain was isolated as described (Jalkanen et al., 1987) . Briefly, after a 24 h incubation with 35S-sulphate, cells were scraped into cold PBS in the presence of proteinase inhibitors and centrifuged for 10 min at 300 g, and the pellet was exposed to trypsin (20 mg ml-') for 10 min on an ice bath. The reaction was stopped by adding 100 mg ml-' of soybean trypsin inhibitor. After a further centrifugation, the trypsin-cleavable ectodomain was obtained in the supernatant (Rapraeger and Bernfield, 1985) .
Quantification of syndecan-J The syndecan-1 ectodomain was quantified by blotting on Zeta-Probe membranes. Briefly, aliquots of trypsin-released 35S-syndecan-1 ectodomain were brought to a final concentration of 8 M urea and equilibrated with loading buffer containing 10 mM Tris-HCl, 8 M urea, 0.1% Triton X-100 (pH 8.0) and were spotted onto Zeta-Probe membranes with a dot-blot microfiltration apparatus (Bio-Rad Laboratories), as described (Buee et al., 1991). After passive filtration, the membranes were extensively washed under vacuum with the P Levy et al loading buffer, then with 50 mM Tris HCl, 150 mM sodium chloride (pH 8.0) and finally with water. The dots were cut out and bound radiolabelled syndecan-1 ectodomain was quantified by scintillation counting.
Glycosaminoglycan (GAG) chains of syndecan-I were characterised by their differential susceptibility to nitrous acid deminative cleavage or chondroitin ABC lyase degradation, as previously reported (Levy et al., 1989) . After nitrous acid degradation of the GAGs, CS chains remain, as judged by their sensitivity to chondroitinase digestion; alternatively, after chondroitin ABC lyase digestion of the GAGs, HS chains remain, identified by their susceptibility to nitrous acid degradation. After treatment, radiosulphate incorporation into HS and CS was quantified by spotting samples onto Zeta-Probe membranes as described above and by counting the corresponding membrane spots.
Gel filtration and ion-exchange chromatography Gel filtration of syndecan-I ectodomain on Sepharose CL-4B (0.9 x 60 cm) was performed in 4 M Gdn HCl containing 50 mM sodium acetate, at a flow rate of 9 ml h-'. Free GAG chains were produced from syndecan-1 ectodomain by #-elimination with alkaline borohydride, as previously described (Levy et al., 1986) . The HS and CS GAG chain sizes were determined after chromatography on Sepharose CL-6B (0.9 x 60 cm) by comparing the Kay determined experimentally with a standard curve of log Mr vs Ka, for GAG chains of various known molecular weights (Wasteson, 1971) . Void and total volumes of the sizing columns were marked by blue dextran and phenol red respectively.
Ion-exchange chromatography of the GAG chains of the syndecan-1 ectodomain was performed on a DEAE-Sephacel column (1 x 3 cm). After washing the column with 50 mM Tris-HCl, 50 mm sodium chloride (pH 6.8), elution was performed with a linear 50 ml gradient of 50-800 mM sodium chloride in the same buffer under a constant flow rate of 5 ml h-. Fractions (2 ml) were collected. The gradient was determined by conductivity measurements of the fractions (radiometer) and radioactivity was measured.
Heparanase activity Preparation of 35S-labelled HS from Caco-2-H cells Caco-2-H cells were labelled with 35S-sulphate for 24 h. 35S-GAG were prepared by alkaline borohydride degradation as described above. GAGs were digested with chondroitin ABC lyase and the degradation products were removed by passing through a Sepharose Cl-6B column equilibrated with 4 M Gdn HCl containing 50 mM sodium acetate. The radioactive peak in the void volume was collected, dialysed and concentrated. This material treated with nitrous acid was completely degraded and was thus identified as pure HS.
Cell extracts Once confluent, cell monolayers of Caco-2-H, Caco-2-MT and Caco-2-T cells were washed 3 times with PBS and detached from the dish by gentle shaking at 37°C in the presence of calcium-and magnesium-free PBS containing 2 mM EDTA. Cells were collected by centrifugation at 900 x g for 10 min at 4°C, washed 3 times with PBS and freeze-dried. The lyophilised cells were then dispersed in 0.1% Triton X-100 and sonicated for 30 s in an ice bath (Ricoveri and Cappelleti, 1986 inhibitor of P-glucuronidase (Ricoveri and Cappelleti, 1986) .
Digestions were carried out in duplicate using a boiled extract as a control. At the end of incubation, the mixture was centrifuged at 10000 x g for 5 min and the supernatant was applied to a Sepharose Cl-6B column, as described above.
Intact cells Equal amounts (30 x 103 d.p.m.) of 35S-HS from control Caco-2-H cells were added to confluent cell monolayers of Caco-2-H, Caco-2-MT or Caco-2-T cells. The medium was buffered by adding 1 M Hepes (pH 7.4) to a final concentration of 10 mM. The cells were incubated for the indicated times with gentle-shaking. At the end of incubation, the medium was harvested, centrifuged at 10 000 x g for 5 min and fractionated, as described for cell extracts.
Statistical analysis
Results are means + s.d. for the indicated numbers of experiments with different cell preparations.
Results

Membrane-anchored PGs
The PGs from control and oncogene-transfected Caco-2 cells were examined for the presence of lipophilic moieties by hydrophobic chromatography on Octyl-Sepharose CL-4B, a procedure currently used to identify PG species that are integral components of the plasma membrane. Chromatography of detergent-extracted PGs generated two sulphate-containing peaks (Figure 1 ). The first peak, which eluted before the beginning of the gradient, constituted the unbound fractions. The second peak, requiring a detergent-containing buffer to be displaced from the column, contained 35S-labelled PGs which bound to Octyl-Sepharose through hydrophobic interactions. This bound material comprised the lipophilic PGs. In control Caco-2-H cells (Figure la) , 57.6% of the total 35S-labelled PGs bound to the column, and the hydrophobic PG fraction eluted at 0.14% Triton X-100. In contrast, in the oncogene-transfected Caco-2-MT cells (Figure lb) and Caco-2-T cells (Figure Ic) , only 40.5% and 37.2% of the total 35S-labelled PGs bound to the column, and the hydrophobic PG fractions eluted at Triton X-100 concentrations of 0.11% and 0.09% respectively. These results indicate that expression of Ha-ras or Py-MT oncogenes in Caco-2 cells induced a decrease in the amount of membrane-anchored PGs. As indicated in Table I , this decrease was selectively accounted for by a decrease in syndecan-1 since the amount of the other lipophilic PGs was not modified in oncogene-transfected Caco-2-MT and Caco-2T cells.
Syndecan-J expression
Among the membrane-anchored PGs, syndecan-I is known to play a central role in the maintenance of the epithelial phenotype. We therefore examined the expression of this PG in Caco-2 cells to determine if it was altered by Ha-ras or Py-MT oncogenes. Figure 2 shows the results of Northern blot analysis using a cDNA probe specific for syndecan-1 (Saunders et al., 1989) . In control Caco-2 cells, two mRNA transcripts of 2.6 and 3.4 kb were detected (Figure 2a ), in accordance with the results reported for other cell types (Saunders et al., 1989; Kirjavainen et al., 1993; Inki et al., 1994) . In oncogene-transfected Caco-2-MT and Caco-2-T cells, syndecan-1 mRNA transcripts were present in a relative abundance similar to that observed in Caco-2-H cells, as determined by densitometric scanning of the Northern blots and normalisation of the results with respect to the 28S signal (Figure 2a) . These results indicate that neither Ha-ras nor PY-MT oncogenes modified the amount of syndecan-1 mRNA. Figure 2b shows the results of immunoblot analysis using an anti-syndecan-1 antibody (Jalkanen et al., 1985) . In all three cell lines, this antibody recognised a core protein of approximately 70 kDa, which is in accordance with the published molecular mass of syndecan-1 core protein Na235SO4. 35S incorporation into total membrane-anchored PGs was determined as indicated in Figure 1 . 35S incorporation into syndecan-l was determined after mild trypsin treatment of the cells. Other, lipophilic PGs expressed at the cell surface as trypsin-resistance PGs. CS chains were examined for their specific radioactivity. In the three cell lines, the syndecan-1 ectodomain consisted mainly of HS chains but also possessed some CS chains (Table II) . In control Caco-2-H cells, most of the total 35S-sulphate incorporated into the syndecan-I ectodomain (i.e. 87.9+2.8%) was degraded with nitrous acid, indicating that it consisted of HS chains, whereas CS chains only accounted for 12.1 + 2.8%, as determined by sensitivity to chondroitin ABC lyase. In contrast, in oncogene-transfected Caco-2-MT and Caco-2-T cells, the proportions of "5S-sulphate incorporated into HS chains decreased to 74.1+3.6% and 64.6+5.8% of total "5S-labelling respectively, whereas the respective proportions of 35S-sulphate incorporated into CS chains rose to 25.9+3.6% and 35.4+5.8%. These data provide clear evidence that the functional insertion of Ha-ras or Py-MT oncogenes in Caco-2 cells markedly lowered the specific activity of the syndecan-I ectodomain, and concomitantly reduced the HS/CS specific activity ratio.
Polyanionic properties of GAG side-chains in the syndecan-I ectodomain To establish the basis of the post-translational modifications of the syndecan-l ectodomain in oncogene-transfected Caco-2-MT and Caco-2-T cells, we examined two major characteristics of their GAG side-chains: the degree of sulphation and molecular mass.
We first determined the extent of sulphation of the syndecan-l GAG side-chains to see if it was modified by oncogene transfection. For this purpose, the polyanionic properties of the "S-labelled GAGs released from the syndecan-1 ectodomain by alkaline borohydride were investigated by ion-exchange chromatography on DEAESephacel (Figure 3) . GAGs from Caco-2-MT and Caco-2-T cells (Figure 3b and 3c) bound less tightly to the column than GAGs from control Caco-2-H cells (Figure 3a (1 x 2cm). After extensive washing of the column with a buffer containing 50mM Tris-50 mm sodium chloride (pH 6.8), the elution was performed with a linear gradient of 50mM-800mM sodium chloride in the same buffer. The resulting 2ml fractions were collected and analysed for radioactivity. control Caco-2-H cells eluted as a peak with a Kay of 0.50 (Figure 4a ), whereas syndecan-1 from transfected Caco-2-MT and Caco-2-T cells eluted as a peak with Kay values of 0.62 ( Figure 4b ) and 0.66 (Figure 4c ) respectively. These results show that the ectodomain of syndecan-I synthesised by Haras or Py-MT oncogene-transfected Caco-2 cells exhibited smaller hydrodynamic sizes than that of syndecan-1 from control Caco-2-H cells.
GAG chain length of syndecan-J ectodomain To determine whether the lower relative molecular mass of syndecan-l ectodomain in transfected Caco-2 cells was due to a reduction in its GAG chain length, "S-labelled ectodomains were subjected to alkaline fl-elimination and then to degradation with either chondroitin ABC lyase or nitrous acid. (Table III) .
Syndecan-1 in oncogene-transfected Caco-2 cells
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Heparanase degradative activity in oncogene-transfected Caco-2-MT and Caco-2-T cells The reduced hydrodynamic size of the HS chains of the syndecan-1 ectodomain in oncogene-transfected Caco-2 cells led us to suspect HS degradation by active heparanase in these cells. To test this hypothesis, intact control Caco-2-H cells and oncogene-transfected Caco-2-MT and Caco-2-T cells, as well as cell extracts from all three cell lines, were compared for heparanase degradative activity using 35S-labelled HS extracted from control Caco-2-H cells as a substrate (see Materials and methods).
Incubations were carried out at 370C for 3, 6, 18 and 30 h. The degradation products were analysed by gel chromatography on Sepharose Cl-6B and monitored by scintillation counting. The first set of experiments, carried out with intact Caco-2 cells, showed that neither Caco-2-H cells nor oncogene-transfected Caco-2-MT and Caco-2-T cells contained significant heparanase activity, whatever the incubation time studied (data not shown). With cell extracts of the three cell lines, no appreciable degradation was observed after short incubation periods (3 h or 6 h). By contrast, after 18 h incubation we detected heparanase activity which degraded the HS in the cell extracts from the oncogene-transfected Caco-2 cells. The presence of this activity was indicated by an incompletely resolved, slowly eluting peak of lower molecular weight species than in the control Caco-2-H cells, which displayed no heparanase activity. The elution patterns of Caco-2-MT and Caco-2-T cells after incubation for 18 h are compared in Figure 5b and 5c with the pattern obtained for the control cell extracts (Figure 5a ). However, after an even longer incubation period (30 h), no further degradation was observed (data not shown). These results indicate the presence of heparanase degradative activity in cell extracts from oncogene-transfected Caco-2 cells. (Sanderson et al., 1992; Vainio et al., 1992; Kirjavainen et al., 1993) . In the present study, we provide clear evidence that Ha-ras and PY-MT oncogenes alter syndecan-1 expression at both the translational and post-translational levels. Caco-2-MT and Caco-2-T cells indeed showed a decrease in syndecan-1 protein but not mRNA expression and also exhibited alterations in syndecan-l ectodomain. These alterations consisted of a decrease in the length and degree of sulphation of the GAG chains attached to the protein core together with modification of the GAG composition. Although the main GAG of the syndecan-l ectodomain in control and oncogene-transfected Caco-2 cells consists of HS, a higher proportion of CS was observed in Caco-2-MT and Caco-2-T cells. In agreement with our results, previous authors reported that GAGs isolated from colon tumours contain larger amounts of CS than those from normal colonic mucosa (Tozzo and Wight, 1982; lozzo et al., 1989 ).
We present here, as far as we know, the first evidence for altered glycosylation of syndecan-I associated with malignant progression in human colonic epithelial cells. Other studies have shown that the interactions of syndecans with extracellular matrix components depend on ectodomain glycosylation or sulphation , strongly suggesting a central role for syndecan in cell -matrix adhesion. In the light of these findings, our results are significant, and the post-translational modifications of syndecan-1 in Ha-ras-and Py-MT-transfected Caco-2 cells might provide Caco-2-MT and Caco-2-T cells with a mechanism that would allow the loosening of their attachment to the extracellular matrix and maintain their growth.
The first step in the development of cancer is uncontrolled cell growth. The next critical step is the transition of the tumour from mere growth to invasion and metastasis. During this transition, a series of genetic and molecular events causes tumour cells to increase their production and activation of the enzymes that cleave the extracellular matrix. Activity that degrades ECM components is mediated by a variety of proteases and endoglycosidases, including the plasmin/ plasminogen activator family of serine proteases, the matrix metalloproteinases and the heparanases, which are specific HS PG-degrading endoglycosidases (Stetler-Stevenson et al., 1993) . The present results show that oncogene-transfected Caco-2 cells were able to degrade purified HS, thus reflecting the presence of heparanase activity in these cells. However, this activity fails to be secreted and shows only limited levels. Therefore, the decrease in HS chain size of syndecan-I cannot be solely accounted for by the presence of the heparanase activity and probably also reflects the synthesis by the oncogene-transfected Caco-2 cells of smaller HS chains on the same core protein.
Recent advances in the understanding of HS PGs implicate them as important participants in cell signalling. At the cell surface, syndecan may transduce ECMcytoskeletal actin-mediated signals essential for cell growth. The conserved cytoplasmic domain of syndecans could transmit signalling, directly or indirectly, by specifically interacting with the membrane and cytoplasmic transduction systems. In addition, syndecan may also mediate signalling through interaction with cytoskeletal proteins Carey et al., 1994) . In this connection, Rapraeger speculated that the formation of the syndecan/FGF/tyrosine kinase receptor complex results in phosphorylation of the syndecan itself, thus influencing its interaction with the cytoskeleton or with other receptors such as the cadherins, and thereby directly affecting cell shape and behaviour 
